Report cover image

Rapid Diagnostics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Publisher Global Market Insights
Published Aug 02, 2024
Length 130 Pages
SKU # GMI19157368

Description

Rapid Diagnostics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032


Rapid diagnostics market size is set to record a 9.2% CAGR during 2024-2032 driven by increasing need for timely and accurate disease detection across various healthcare settings. Rapid diagnostic tests offer quick results, which are crucial for managing infectious diseases, such as influenza, and sexually transmitted infections. The growing need for efficiency and speed in diagnostics has also spurred market development. Innovations in molecular diagnostics, immunoassays, and biosensors have enhanced the accuracy and speed of rapid tests, making them more attractive to healthcare providers. Furthermore, the rising prevalence of chronic and infectious diseases globally, coupled with the growing demand for personalized medicine, will drive market growth. As per WHO, chronic diseases account for 41 million deaths annually, representing 74% of all global deaths. The overall industry is divided into product, purchase, technology/platform, distribution channel, end-use, and region. Based on product, the rapid diagnostics market size from the glucose monitoring segment is expected to generate notable revenue by 2032. This is due to the increasing prevalence of diabetes and the critical need for frequent blood glucose testing to manage the condition effectively. Advances in glucose monitoring technologies, such as continuous glucose monitors (CGMs) and portable blood glucose meters, offer patients and healthcare providers rapid and accurate results, enabling better glycemic control and timely adjustments in treatment. In terms of end-use, the rapid diagnostics market from the diagnostic center segment is projected to observe a robust CAGR during 2024 – 2032. This is owing to their pivotal role in providing quick and accurate testing services across a range of conditions. These centers are increasingly adopting rapid diagnostic technologies to enhance patient throughput and improve diagnostic efficiency. Asia Pacific rapid diagnostics industry size will grow between 2024 and 2032 attributed to the rising prevalence of infectious and chronic diseases, such as respiratory infections. Rapid urbanization and industrialization have led to increased health challenges, creating a strong demand for fast and efficient diagnostic solutions. Government initiatives and healthcare policies focused on strengthening disease detection and management will further support regional market development.

Table of Contents

130 Pages
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of infectious disease
3.2.1.2 Technological advancements
3.2.1.3 Increasing popularity of rapid diagnostic tests
3.2.1.4 Rising awareness regarding early diagnosis among people
3.2.1.5 Increasing government initiatives for the diagnosis of infectious diseases
3.2.2 Industry pitfalls and challenges
3.2.2.1 Low accuracy of results
3.2.2.2 Availability of substitute products
3.2.2.3 Stringent regulatory framework
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technological landscape
3.7 New emerging therapies
3.8 GAP analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Infectious disease testing
5.2.1 Respiratory infection testing products
5.2.2 Influenza
5.2.3 Hepatitis
5.2.4 HIV
5.2.5 Other infectious disease tests
5.3 Glucose monitoring
5.4 Cardiometabolic testing
5.5 Coagulation testing products
5.6 Pregnancy and fertility testing
5.7 Tumor/Cancer marker testing products
5.8 Urinalysis testing products
5.9 Cholesterol testing products
5.10 Hematology testing products
5.11 Drug-of-abuse (DoA) testing products
5.12 Fecal occult testing products
5.13 Other products
Chapter 6 Market Estimates and Forecast, By Purchase, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 OTC
6.3 Prescription-based tests
Chapter 7 Market Estimates and Forecast, By Technology/Platform, 2021 – 2032 ($ Mn)
7.1 Flow-through
7.2 Solid phase
7.3 Lateral flow
7.4 Agglutination assays
7.5 Other technologies
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Hospital pharmacies
8.2 Brick and mortar
8.3 E-commerce
8.4 Other distribution channels
Chapter 9 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
9.1 Diagnostic centers
9.2 Homecare settings
9.3 Hospitals and clinics
9.4 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 ACON Laboratories Inc.
11.3 Alfa Scientific Designs Inc.
11.4 Artron Laboratories Inc.
11.5 Becton, Dickinson and Company
11.6 BioMerieux
11.7 Bio-Rad Laboratories
11.8 Danaher Corporation (HemoCue and Radiometer)
11.9 Hologic
11.10 McKesson Medical-Surgical, Inc.
11.11 Meridian Bioscience, Inc.
11.12 QIAGEN N.V.
11.13 Quidel Corporation
11.14 F. Hoffmann-La Roche Ltd.
11.15 Sight Diagnostics Ltd.
11.16 Trinity Biotech
 

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us